# Nuclide record nct07219238 (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/nct07219238/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "nct07219238", "NCT07219238" ;
  schema:name "Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, o"@en ;
  schema:alternateName "PERISCOPE"@en ;
  schema:description "A phase 2/3 trial of FAP-2286 in colorectal cancer and ovarian cancer, run by GE Healthcare, now recruiting."@en ;
  schema:url <https://nuclide.cc/trials/nct07219238/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07219238> ;
  nuclide:status "recruiting" ;
  nuclide:tag "ctgov-ingest" ;
  nuclide:phase "2/3" ;
  nuclide:related <https://nuclide.cc/isotopes/ga-68/> ;
  nuclide:drugs <https://nuclide.cc/drugs/fap-2286/> ;
  nuclide:companies <https://nuclide.cc/companies/ge-healthcare/> .